Align Technology, Inc. (ALGN) Stock Price & Analysis
Align Technology, Inc. (ALGN) closed at USD 155.51 on Thursday, October 22, 2026, up 2.74% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 151.37; the Oct 22, 2026 session ranged USD 151.44–155.94 on volume of 1,160,167 shares. Market capitalization is $11.05B, with a 52-week range of USD 130.23–200.44 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ALGN.md
Key facts (ALGN)
- Last four reported quarters (through Jun 30, 2026): revenue $4.14B, net income $414M (10.0% margin), free cash flow $634M (SEC filings).
- 1 of 80 tracked superinvestors hold ALGN (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Total return with dividends: 1Y +14.3% vs S&P 500 +14.9%; 5Y -73.7% vs S&P 500 +80.3%.
- Next earnings: 2026-10-28, EPS estimate USD 2.77, revenue estimate $1.00B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ALGN)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $3.95B | $3.73B | $3.86B | $4.00B | $4.03B | $4.14B |
| Gross profit | $2.94B | $2.63B | $2.71B | $2.80B | $2.71B | — |
| Operating income | $976M | $643M | $643M | $608M | $546M | $548M |
| Net income | $772M | $362M | $445M | $421M | $410M | $414M |
| EPS (diluted) | $9.69 | $4.61 | $5.81 | $5.62 | $5.65 | — |
| Free cash flow | $771M | $277M | $608M | $623M | $491M | $634M |
| Gross margin | 74.3% | 70.5% | 70.1% | 70.0% | 67.2% | — |
| Operating margin | 24.7% | 17.2% | 16.7% | 15.2% | 13.5% | 13.2% |
| Net margin | 19.5% | 9.7% | 11.5% | 10.5% | 10.2% | 10.0% |
| Revenue growth | +59.9% | -5.5% | +3.4% | +3.5% | +0.9% | — |
| Cash + short-term investments | $1.17B | $1000M | $973M | $1.04B | — | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (ALGN)
P/E at fiscal year-ends: Dec 2025 27.6x, Dec 2024 37.1x, Dec 2023 47.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (ALGN)
1 of 80 tracked investors hold ALGN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Ruane Cunniff | Ruane Cunniff LP | 3.07% | $198M | Reduced -2.9% |
Analysts (ALGN)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Mizuho | Target lowered | Outperform | $220 → $200 |
| 2026-10-21 | Piper Sandler | Target lowered | Overweight | $235 → $205 |
| 2026-10-15 | Baird | Downgrade | Outperform → Neutral | $218 → $162 |
| 2026-10-14 | Leerink Partners | Target lowered | Outperform | $235 → $215 |
| 2026-10-09 | Stifel | Target lowered | Buy | $210 → $175 |
| 2026-10-05 | Evercore ISI Group | Downgrade | Outperform → In-Line | $220 → $155 |
| 2026-07-23 | UBS | Target raised | Neutral | $186 → $189 |
| 2026-07-09 | BMO Capital | Initiated | Outperform | $209 |
Total return (dividends reinvested) (ALGN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +14.3% | -73.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +14.4% | -23.4% |
| Volatility (annualized) | 39.2% | 49.3% |
| Max drawdown | -29.2% (Feb 2026→Oct 2026) | -81.7% (Nov 2021→Oct 2025) |
ALGN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $2.77 | $2.90 | -4.6% | $1.00B | 14 |
| Next quarter (ends Dec 2026) | $3.17 | $3.29 | -3.8% | $1.05B | 14 |
| Current fiscal year (ends Dec 2026) | $11.21 | $11.36 | -1.3% | $4.15B | 15 |
| Next fiscal year (ends Dec 2027) | $12.40 | $12.38 | +0.2% | $4.29B | 16 |
ALGN options: expected move
Options price a move of about ±10.9% (±$16.90) by Oct 30, 2026, which includes earnings on Oct 28, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 92.0% | ±10.9% |
| Nov 6, 2026 | 14 | 66.0% | ±10.7% |
| Nov 13, 2026 | 21 | 67.4% | ±13.2% |
| Nov 20, 2026 | 28 | 59.5% | ±13.3% |
| Nov 27, 2026 | 35 | 53.9% | ±13.4% |
| Dec 4, 2026 | 42 | 50.0% | ±13.7% |
| Dec 18, 2026 | 56 | 48.7% | ±15.3% |
| Jan 15, 2027 | 84 | 43.5% | ±16.7% |
30-day implied volatility 56% vs 29.8% realized over the last 30 trading days. Put/call ratio (volume) 0.81. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 155.51 |
|---|---|
| Change | ▲ 2.74% (up) |
| Previous Close | USD 151.37 |
| Open | USD 151.5 |
| Day Range | USD 151.44 – 155.94 |
| 52-Week Range | USD 130.23 – 200.44 |
| Volume | 1,160,167 shares |
| Market Cap | $11.05B |
| Exchange | NMS |
Technical Analysis (ALGN)
Nexqual's technical model rates ALGN "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 60.81 (neutral) |
| vs SMA50 | Above (USD 152.51) |
| MACD | -0.09 (negative) |
Earnings (ALGN)
| Next Earnings Date | 2026-10-28 |
|---|---|
| EPS Estimate | USD 2.77 |
| Revenue Estimate | $1.00B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.64 vs est 2.6 ▲ beat |
| 2026-03-31 | USD 2.58 vs est 2.29 ▲ beat |
| 2025-12-31 | USD 3.29 vs est 2.97 ▲ beat |
| 2025-09-30 | USD 2.61 vs est 2.41 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (ALGN)
| Total Revenue | $4.14B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +4.30% |
| Gross Margin | +70.74% |
| Operating Margin | +18.25% |
| Profit Margin | +9.99% |
| ROE | +10.15% |
| Debt / Equity | 0.03 |
| Current Ratio | 1.4 |
| Total Cash | $1.10B |
| Total Debt | $120.84M |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Ownership (ALGN)
| Insider Ownership | +6.13% |
|---|---|
| Institutional Ownership | +105.41% |
| Shares Outstanding | 71.04M |
| Float | 66.84M |
| Short % of Float | +6.76% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| COO | The Cooper Companies, Inc. | USD 61.65 | ▲ 4.54% |
| RGEN | Repligen Corporation | USD 178.71 | ▼ 0.72% |
| AVTR | Avantor, Inc. | USD 17.15 | ▼ 0.64% |
| BAX | Baxter International Inc. | USD 25.65 | ▲ 3.85% |
| ATR | AptarGroup, Inc. | USD 128.1 | ▲ 1.97% |
| SOLV | Solventum Corporation | USD 87.45 | ▲ 0.9% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt